PubRank

Katherine E Warren

Author PubWeight™ 19.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas. J Neurosurg Pediatr 2014 2.07
2 Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 2007 1.51
3 Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol 2011 1.02
4 Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas. J Neurooncol 2008 1.02
5 Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 2015 0.91
6 Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathol Commun 2014 0.89
7 Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma. J Neurooncol 2011 0.88
8 Unclear standard of care for pediatric high grade glioma patients. J Neurooncol 2013 0.86
9 Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors. Cancer Chemother Pharmacol 2009 0.86
10 Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 2012 0.83
11 Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer 2013 0.83
12 Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition. J Neuropathol Exp Neurol 2015 0.82
13 Measurements of the pons as a biomarker of progression for pediatric DIPG. J Neurooncol 2013 0.81
14 Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI. J Neurooncol 2012 0.80
15 Novel therapeutic delivery approaches in development for pediatric gliomas. CNS Oncol 2013 0.77
16 Patient and Public Risks of Powdered Alcohol: A Citywide Case Study to Prevent Abuse. Ann Intern Med 2016 0.76
17 Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model. Cancer Chemother Pharmacol 2015 0.76
18 The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates. Cancer Chemother Pharmacol 2011 0.76
19 What do parents want to know when considering autopsy for their child with cancer? J Pediatr Hematol Oncol 2014 0.75
20 Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy. Childs Nerv Syst 2008 0.75
21 Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatr Blood Cancer 2009 0.75
22 Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta). Comp Med 2013 0.75
23 Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors. Pediatr Blood Cancer 2015 0.75
24 Role of early postradiation magnetic resonance imaging scans in children with diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 2012 0.75
25 Measuring the pons: a non-invasive biomarker for pediatric diffuse intrinsic pontine glioma. CNS Oncol 2014 0.75